# A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)

> **NCT04660617** · — · UNKNOWN · sponsor: **West China Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04660617
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660617, "A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04660617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*